The South African government has decided to suspend the Oxford AstraZeneca COVID-19 vaccine rollout plan after clinical trials show poor results.
South Africa has reportedly announced that the country's COVID-19 vaccine rollout with Oxford AstraZeneca has been suspended. This comes after South African Health Minister Dr. Zweli Mkhize publicly revealed that the latest trial data showed that the Oxford AstraZeneca vaccine offers limited protection against the latest coronavirus variant, 501Y.V2. South Africa received the first batch of one million doses of the vaccine from India last Monday. The health department's vaccine rollout plan was set to commence this February with the first stage aimed at healthcare workers.